Clarivate logo

Clarivate

CLVT | NYSE
Chart Builder DCF Calculator
$1.93
+$0.04 (+2.12%)
At close: Sep 21, 2026, 4:00 PM ET
$1.92
-$0.01 (-0.52%)
After-hours: Sep 21, 2026, 6:31 PM ET
+2.12%

Rating

Updated: Aug 29, 2026
44.6
Fundamentals Average
Market Sentiment Bullish
Moat None

Key Statistics

Market Data

Market Cap $1.23B
1D Range
1.89 1.97
52W Range
1.66 4.14

Valuation (TTM)

PE -3.71
PB 0.27
EV/EBITDA 10.98

Valuation (NTM)

Forward PE 2.36
Forward PEG -1.09
Price Target $2
Loading financial charts...

Profile

Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual prop...

Sector Technology
Employees 12,000
IPO Date Oct 28, 2018
Fiscal Year January - December

Latest News

Clarivate PLC (NYSE:CLVT) Receives $3.02 Consensus Price Target from Brokerages

1 day ago · defenseworld.net

Clarivate PLC (NYSE:CLVT) Receives $3.02 Consensus Price Target from Brokerages
Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities

4 days ago · prnewswire.com

Clarivate Commences Offer to Purchase for Cash Certain of its Outstanding Debt Securities
Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs

5 days ago · gurufocus.com

Clarivate Reveals Citation Laureates 2026 Recognizing Transformative Scientific Breakthroughs
Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member

21 days ago · globenewswire.com

Accuserve Solutions Appoints Maroun S. Mourad as an Independent Board Member
Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?

1 month ago · fool.com

Clarivate Director Cornick Buys 900,000 Shares for $1.7 Million. What Does This Tell Investors About the Outlook for 2026?
Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development

2 months ago · prnewswire.com

Clarivate Scales Agentic AI Across Cortellis to Advance Drug Development
Clarivate Q2 Earnings Call Highlights

2 months ago · marketbeat.com

Clarivate Q2 Earnings Call Highlights
Clarivate Plc (CLVT) Q2 2026 Earnings Call Transcript

2 months ago · seekingalpha.com

Clarivate Plc (CLVT) Q2 2026 Earnings Call Transcript
Clarivate (CLVT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

2 months ago · zacks.com

Clarivate (CLVT) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Clarivate PLC (CLVT) Q2 Earnings and Revenues Beat Estimates

2 months ago · zacks.com

Clarivate PLC (CLVT) Q2 Earnings and Revenues Beat Estimates

Earnings

Next Earnings
Nov 4, 2026
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
6
Consensus
Hold
Price Target
$2
Upside
+3.63%
Buy (1)
Hold (3)
Sell (2)
Analyst Details

© 2026 bestshares.com. All rights reserved.